A randomised controlled trial of atomoxetine for adults with Attention Deficit Hyperactivity Disorder (ADHD)

Phase 4

• Conditions: Attention deficit hyperactivity disorder; Mental Health - Other mental health disorders

• Registration Number: ACTRN12610000432011
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-05-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 68

Inclusion Criteria

Aged at least 18 years
Diagnosis of ADHD

Exclusion Criteria

1. Current or past diagnosis of psychotic disorders, pervasive development disorders, intellectual impairment,
2. History of serious neurologic illnesses including stroke, brain tumours, head trauma, multiple sclerosis, epilepsy, movement disorders or migraine in treatment
3. drug dependency on alcohol or illicit substances
4. Pregnancy or breast feeding

Study & Design

• Study Type: Interventional
• Study Design: Not specified